<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38087445</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1533-3450</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of the American Society of Nephrology : JASN</Title><ISOAbbreviation>J Am Soc Nephrol</ISOAbbreviation></Journal><ArticleTitle>Predicting Outcomes in Nephrology: Lots of Tools, Limited Uptake: How Do We Move Forward?</ArticleTitle><Pagination><StartPage>361</StartPage><EndPage>363</EndPage><MedlinePgn>361-363</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1681/ASN.0000000000000288</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Adeera</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2438-8401</Identifier><AffiliationInfo><Affiliation>Medicine, Division of Nephrology, University of British Columbia, St Paul's Hospital, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Nephrol</MedlineTA><NlmUniqueID>9013836</NlmUniqueID><ISSNLinking>1046-6673</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>doi: 10.1681/ASN.0000000000000285</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D009398" MajorTopicYN="Y">Nephrology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001692" MajorTopicYN="N">Biological Transport</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>A. Levin reports Consultancy: Astra Zeneca, Bayer, Boeingher Ingleheim; Chinook Therapeutics; GSK; Janssen, Kidney Foundation of Canada; NIH, Novo Nordisk; Occuryx/Certa, Otsuka, REATA; Research Funding: Astra Zeneca; Boehringer Ingelheim; Canadian Institute of Health Research (CIHR); CITF (Canadian Immunology Task Force), GSK, Health Research BC, Kidney Foundation of Canada; MOH BC, Shared Care BC; Honoraria: AstraZeneca; Bayer; GSK; Janssen; NIH; Advisory or Leadership Role: AstraZeneca, Boehringer Ingelheim, and NIDDK, DSMB for NIDDK, Kidney Precision Medicine, U Washington Kidney Research Institute Scientific Advisory Committee; International Society of Nephrology Research Committee; KRESCENT (Kidney Scientist Education Research National Training Program); GSK, Chinook Therapeutics, BC Renal (Exec Director), Steering Committee Chair CURE Consortium, CADTH, CITF, Co Lead Long Covid Web Grant; PI CanSOLVE CKD; and Other Interests or Relationships: CREDENCE National Coordinator from Janssen, directed to her academic team; NIDDK CURE Chair Steering Committee; International Society of Nephrology; Canadian Society of Nephrology; Kidney Foundation of Canada, Steering Committee ALIGN trial, DSMB Chair RESOLVE Trial (Australian Clinical Trial Network)l ASPIRE Trial (ACTN), Executive Steering Committee AstraZeneca Clinical Trial.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>0</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38087445</ArticleId><ArticleId IdType="pmc">PMC10914199</ArticleId><ArticleId IdType="doi">10.1681/ASN.0000000000000288</ArticleId><ArticleId IdType="pii">00001751-202403000-00011</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hemann BA, Bimson WF, Taylor AJ. The Framingham Risk Score: an appraisal of its benefits and limitations. Am Heart Hosp J. 2007;5(2):91&#x2013;96. doi:10.1111/j.1541-9215.2007.06350.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1541-9215.2007.06350.x</ArticleId><ArticleId IdType="pubmed">17478974</ArticleId></ArticleIdList></Reference><Reference><Citation>Gage BF van Walraven C Pearce L, et al. . Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation. 2004;110(16):2287&#x2013;2292. doi:10.1161/01.CIR.0000145172.55640.93</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000145172.55640.93</ArticleId><ArticleId IdType="pubmed">15477396</ArticleId></ArticleIdList></Reference><Reference><Citation>Arozullah AM, Daley J, Henderson WG, Khuri SF. Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program. Ann Surg. 2000;232(2):242&#x2013;253. doi:10.1097/00000658-200008000-00015</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-200008000-00015</ArticleId><ArticleId IdType="pmc">PMC1421137</ArticleId><ArticleId IdType="pubmed">10903604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385&#x2013;397. doi:10.1007/s00198-007-0543-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-007-0543-5</ArticleId><ArticleId IdType="pmc">PMC2267485</ArticleId><ArticleId IdType="pubmed">18292978</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Grams ME, Inker LA. Uses of GFR and albuminuria level in acute and chronic kidney disease. N Engl J Med. 2022;386(22):2120&#x2013;2128. doi:10.1056/NEJMra2201153</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2201153</ArticleId><ArticleId IdType="pubmed">35648704</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SS Coresh J Pencina MJ, et al. . Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association. Circulation. 2023. doi:10.1161/CIR.0000000000001191</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001191</ArticleId><ArticleId IdType="pubmed">37947094</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangri N Stevens LA Griffith J, et al. . A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553&#x2013;1559. doi:10.1001/jama.2011.451</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2011.451</ArticleId><ArticleId IdType="pubmed">21482743</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen LM, Ruthazer R, Moss AH, Germain MJ. Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol. 2010;5(1):72&#x2013;79. doi:10.2215/CJN.03860609</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.03860609</ArticleId><ArticleId IdType="pmc">PMC2801643</ArticleId><ArticleId IdType="pubmed">19965531</ArticleId></ArticleIdList></Reference><Reference><Citation>Massie AB Leanza J Fahmy LM, et al. . A risk index for living donor kidney transplantation. Am J Transplant. 2016;16(7):2077&#x2013;2084. doi:10.1111/ajt.13709</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.13709</ArticleId><ArticleId IdType="pmc">PMC6114098</ArticleId><ArticleId IdType="pubmed">26752290</ArticleId></ArticleIdList></Reference><Reference><Citation>Milders J Ramspek C Janse R, et al. . Prognostic models in nephrology: where do we stand and where do we go from here? Mapping out the evidence in a scoping review. JASN. 2024;35(1):xx&#x2013;xx. doi:10.1681/ASN.0000000000000285</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.0000000000000285</ArticleId><ArticleId IdType="pmc">PMC10914213</ArticleId><ArticleId IdType="pubmed">38082484</ArticleId></ArticleIdList></Reference><Reference><Citation>Potok OA, Nguyen HA, Abdelmalek JA, Beben T, Woodell TB, Rifkin DE. Patients, &#x2018;nephrologists,&#x2019; and predicted estimations of ESKD risk compared with 2-year incidence of ESKD. Clin J Am Soc Nephrol. 2019;14(2):206&#x2013;212. doi:10.2215/CJN.07970718</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.07970718</ArticleId><ArticleId IdType="pmc">PMC6390919</ArticleId><ArticleId IdType="pubmed">30630859</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuningas K, Stringer S, Cockwell P, Khawaja A, Inston N. Is there a role of the kidney failure risk equation in optimizing timing of vascular access creation in pre-dialysis patients? Kidney Int Rep. 2023;8:2665&#x2013;2676. doi: 10.1177/11297298221084799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11297298221084799</ArticleId><ArticleId IdType="pubmed">35343295</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>